Functional Neuromodulation Announces CEO Leadership Transition

Todd Langevin named CEO

MINNEAPOLIS, Jan. 25, 2019 -- (Healthcare Sales & Marketing Network) -- Functional Neuromodulation Ltd. ("FNM" or the "Company"), a medical device company focused on bringing to market DBS-f, an implantable d... Devices, Neurology, Personnel Functional Neuromodulation, DBS-f, deep brain stimulation, Alzheimer's disease

Source: HSMN NewsFeed - January 25, 2019 Category: Pharmaceuticals Source Type: news